Kirr Marbach & CO LLC Eli Lilly & CO Transaction History

Kirr Marbach & CO LLC

$376 Million
Q1 2024

A detailed history of Kirr Marbach & CO LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Kirr Marbach & CO LLC holds 2,068 shares of LLY stock, worth $1.89 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares

2,068

Previous 5,782 64.23%

Holding current value

$1.89 Million

Previous $3.37 Million 52.28%

% of portfolio

0.43%

Previous 0.97%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	SELL	$592.2 - $792.28 $2.2 Million - $2.94 Million	-3,714 Reduced 64.23%	2,068 $1.61 Million
Q3 2023 Oct 17, 2023	BUY	$434.7 - $599.3 $38,253 - $52,738	88 Added 1.55%	5,782 $3.11 Million
Q4 2022 Jan 20, 2023	SELL	$321.55 - $374.67 $115,436 - $134,506	-359 Reduced 5.93%	5,694 $0
Q3 2021 Oct 28, 2021	SELL	$221.6 - $272.71 $113,680 - $139,900	-513 Reduced 7.81%	6,053 $1.4 Million
Q1 2021 Apr 19, 2021	SELL	$164.32 - $212.72 $4,929 - $6,381	-30 Reduced 0.45%	6,566 $1.23 Million

Q4 2020 Jan 21, 2021	SELL	$130.46 - $172.63 $2,609 - $3,452	-20 Reduced 0.3%	6,596 $1.11 Million
Q3 2020 Oct 19, 2020	SELL	$146.22 - $169.13 $7,311 - $8,456	-50 Reduced 0.75%	6,616 $979,000
Q2 2020 Jul 17, 2020	SELL	$136.42 - $164.18 $63,708 - $76,672	-467 Reduced 6.55%	6,666 $1.09 Million
Q1 2020 Apr 20, 2020	SELL	$119.05 - $147.35 $19,048 - $23,576	-160 Reduced 2.19%	7,133 $989,000
Q4 2019 Jan 27, 2020	BUY	$106.92 - $132.43 $21,384 - $26,486	200 Added 2.82%	7,293 $959,000
Q4 2018 Jan 18, 2019	BUY	$105.9 - $118.64 $6,354 - $7,118	60 Added 0.85%	7,093 $821,000
Q2 2018 Jul 17, 2018	SELL	$75.7 - $86.88 $11,355 - $13,032	-150 Reduced 2.09%	7,033 $600,000
Q3 2017 Oct 23, 2017	BUY	$77.07 - $85.54 $553,593 - $614,433	7,183	7,183 $614,000

Others Institutions Holding LLY

# of Institutions

3,721

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $869B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kirr Marbach & CO LLC , based on Form 13F filings with the SEC.

News

Stay updated on Kirr Marbach & CO LLC with notifications on news.

Account

Kirr Marbach & CO LLC Eli Lilly & CO Transaction History